{"name":"Mark Lebwohl","slug":"mark-lebwohl","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQbTNaNkhpM0lXOHc2OG9SM25hbGVlSlNwdXI3Sjh0S3RYLTgwY0R5T1czQlh2S2ZpbDZuZGNCRTVLcVpzeDdjMWJ1RjgzejR2akk0Z0NlSjBvTV9NQ3JySm9raWRMbHVYZmFXY1dreExiRm04MjVLYnU0S2dPVjYtMkNiNWhjZnBNczk4VER4MHJfaEp5Ql83MzZVQWxHZU5acVpHM1B0SEg2YUdLcElzUkFFcWdiWVhWQUFHMEFQUFRWdlk?oc=5","date":"2026-02-18","type":"trial","source":"TechTarget","summary":"Lilly's Zepbound–Taltz combo wins again in obesity, psoriasis study - TechTarget","headline":"Lilly's Zepbound–Taltz combo wins again in obesity, psoriasis study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOVkZuM2pTcUpJcTl5akFvdjlPOVRQLVJKcTFld3U1U3R3OWp0ZzlMTUZLUlV6MUNYeU5RbkFNemFvWWstUHFrRGR0X1BrbDMwaTI1NXA2NTdDSF95SDE0bmVCakdsU2tSNU9RcHc5Zlh3eWxJbHlaNHJiRHhrRmtSc3IyMW9rWDc5NFlmR3pUNW9XRXctMzJkYUlqQjMtaEFFS3lIQlBfZjJaWXhUeWNtcmxCZEF5RVRaWVBWTFRBRVlfcUpQWU1MRkNwN1hfTjFXWlFwOWxnLWtsemNwWDlyYTh1bm5DQUUweTQtZ0Y0bGtEYm5ydHN5VWNFWFh5LXNFZGVzUUd2MVd4Z3Fj?oc=5","date":"2025-10-22","type":"trial","source":"BioSpace","summary":"LEO Pharma Reinforces Leadership in Medical Dermatology with New Data from Across Its Portfolio at 2025 Fall Clinical Dermatology Conference - BioSpace","headline":"LEO Pharma Reinforces Leadership in Medical Dermatology with New Data from Across Its Portfolio at 2025 Fall Clinical De","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPdkI3X1ZONG8zSmhObVZCZTFxNzBPQVUwSDZHQXEyUHZaVXo2YUtfMzZUZDZVVURBMHJ6cWpFQWJWNWZheHhmUS1TUzdkNlg4TDR5dXZ1bHZnQjVxRk1ETmNCa2J2bmU2dlRUQk1fQnpVU0NLOUdOdWxELUJCdmc1Wk5SWlNXWmREM2w1YWN1QmUtM2hWNnJoT0tDeWY5aURUOXU2LVFqWXRZX1RnaFRHdFNQM18?oc=5","date":"2025-10-01","type":"pipeline","source":"HCPLive","summary":"Highlighting Recent Findings on Icotrokinra, Other Psoriasis Developments, with Mark Lebwohl, MD - HCPLive","headline":"Highlighting Recent Findings on Icotrokinra, Other Psoriasis Developments, with Mark Lebwohl, MD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNdGlhdWhPX3NRQzJWeEVxSlZCYi1KUktLNVk1bXRGNlowMXp6T0Q2NEswdEgxYWJXWEJJcHdxZjhrU3E2QUo1eTAzSHFoSGg3aV9UNXdGVUY1OGw1RUJJTXVlQ1QzdGJtMFdpSDJidncwREl5UDBCRGJQN0pRb1hVa3pva3p1aWZmdHlWc1paMUpMUlppZ1NoZjBpOUZNaUVlZ1lON2FwRFh2RTBiWG5CUnNGaGxnNWFz?oc=5","date":"2025-09-30","type":"regulatory","source":"Fierce Pharma","summary":"Novartis kicks off BTK competition in immunology with FDA approval for Rhapsido in chronic hives - Fierce Pharma","headline":"Novartis kicks off BTK competition in immunology with FDA approval for Rhapsido in chronic hives","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNZ21FeFdFM0liNzBqTlMxNk9QZEJId0hUT1Q0bFBRdVpyaXZPMXRMdzJhRlFINUhaeWdVU1pxaVZCeGJPVFJKb1Q0U182ekVQU1BLV255Um5TTGJwaGlDbXFHNy1fSHpSa0FUX3pMTVoxU3J5aUZYb2xhYnBBTnBJMmtCc0w3aXAyM09jYjRJMjlXQQ?oc=5","date":"2025-08-21","type":"pipeline","source":"Dermatology Times","summary":"Bridge to Relief: Art Garfunkel's Psoriatic Journey - Dermatology Times","headline":"Bridge to Relief: Art Garfunkel's Psoriatic Journey","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOakdrMDlRNDhLSVh2enBqS184dmF2UkRKVXB6XzFPVUdzYjZkc0xWU2h6cnFqbVI0LXVFcTR6bVl5M1cySWdjYmlBVWJlcXNBYmZQMl9KTkVKUTFxY1JzdkwzVmZzVGJXNDRFbHRCRUpkdnZxU1F1c0dWWFRMU25laUtXQmtNRWxhdnBjUU02eGQ2M1hzRnM0ckgyUjBrZjJ2aWJuUFJmVXJWV29vdUpsSm5OZlFRVVBPT1RZQWIybVpiU0xEcXFGT2RqTkpsV3NuN3c?oc=5","date":"2025-03-13","type":"patent","source":"BioPharma APAC","summary":"Celltrion Launches STEQEYMA®, a Biosimilar to STELARA®, in the U.S. at an 85% Lower WAC List Price - BioPharma APAC","headline":"Celltrion Launches STEQEYMA®, a Biosimilar to STELARA®, in the U.S. at an 85% Lower WAC List Price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQTEs4V25DeVEzWGZYRXl6cVV5UnpKeGgwUU5xQ3dOUGQ0TUtJNW90dDlGaDBKM1lxTjl1NjBKd3RJVDRfbm5CUVE2SEZpRTM5cVJJU1pvUXl3eEFPa3pRbTJDcnQ5cm50UWUyS2NZV25yeTJ2NVdjQ1ozVmt5UjgzVGxJblRra3NqcnktUzB1T3lxSDA?oc=5","date":"2025-03-13","type":"patent","source":"The Pharma Letter","summary":"Steqeyma, a biosimilar to Stelara, now available in the USA - The Pharma Letter","headline":"Steqeyma, a biosimilar to Stelara, now available in the USA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQQTlLOUUxWUp1RU5IUlljeWRCMWZxTnM0R1pyVEhVdl9heFlnTkpodnE2dk1rc19zbVZ2MnczeVVTWWlmVVlvUnRsb01pN25xc2JGMXREQTVCRm9RdlpqaDE5dDlwYzVnRWJmS0IzR1RpdnFLVU5lWm1RV3E4VUdNUTY5OWRoLTZjX1FTUWx0Mm02Rm5OV0s0QVJJNFlkVmx0R3o2bFJvcWRNeUtQWWRHbldlU0RGVFliMWhWbVc2MTNtZG5ZaFUtZFMySjNHSTRq?oc=5","date":"2023-02-09","type":"pipeline","source":"European Pharmaceutical Review","summary":"Oral difelikefalin could relieve itching in notalgia paresthetica - European Pharmaceutical Review","headline":"Oral difelikefalin could relieve itching in notalgia paresthetica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPYi0wV2lYZ2pwdVdyQXpiUzFLN2N0SURBLWg2TnNhUU41RUZkY2Z2dUF4Mms5ZkRyUXlWYkFuTVdINGppR05CRHplY25oWUE2SkhxTnBTMHZIcWpYQS1xWVM2MW43Yl9JOGpVbVYtcXlKZE5ZWUttVE0temZxcGpaa0ROVDI2SEZqZU1VRU9NMmsyVHk3VTI0SXllV21lVUlNSVE?oc=5","date":"2022-07-11","type":"pipeline","source":"Pharma Voice","summary":"Behind the new topical treatment set to disrupt the psoriasis market - Pharma Voice","headline":"Behind the new topical treatment set to disrupt the psoriasis market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOZ2FaMmJJT0NUUmt3am1SU09EUDVNQWJVVE5RczBvMkY0V1VWa0gzU2I4UEdyZ2FtQmVZSmgtQ1l1RURnT0VWNDMxLWhLaHgtSHMyVG1UOXM5eV9FY01lV2publhRSDYxbm9BcWNKakthRnFONFc0bm14Uy00TXliTGx0R1FneGJ6bVJ0RGJHdUFBdXUtRFZmOE9ZaVNyOFRGYkphM2ZqemhDTjFXN24yQjVqRG43S0tlT25GVzdqYWpCbVFw?oc=5","date":"2021-04-26","type":"trial","source":"upi.com","summary":"New psoriasis drug shows 'night and day difference' in clinical trials - upi.com","headline":"New psoriasis drug shows 'night and day difference' in clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9zVExFTEJNZ0c3b0ZsT0ROSGpMMFgtX0FBbXpwVExPamRrdWhIbHNSbFJGd1NCRkVxa3RFV0tzWVhWZWx6MDZGWUw3Y19YOVY5WkxJX0dDT2FLMkNfOXZjdw?oc=5","date":"2021-04-23","type":"pipeline","source":"NEJM","summary":"Bimekizumab versus Secukinumab in Plaque Psoriasis - NEJM","headline":"Bimekizumab versus Secukinumab in Plaque Psoriasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQZW1UTXk5UTd1WEJDZVRES2hfY2VNbHhrRjRIMFBHVG5MOU14TmtLOWxJWHd4UEZaTlk2cTVVZGE1TWF6M0NSSy1Db1JWNFJjeUdRcTBkejNES2JlaHVfYTZyVDlhM1BYb2dOUURfTm5hQ0tnTlhFaUg0TUZUUmdMa3dPRXhmUy1TTkp0cEk4cUpEa25xMlB3Vk9acm9SR2t1MkxZUGF5X1lPbzFhS1JQczVB?oc=5","date":"2021-02-10","type":"pipeline","source":"Healio","summary":"Bimekizumab shows rapid, effective treatment of plaque psoriasis - Healio","headline":"Bimekizumab shows rapid, effective treatment of plaque psoriasis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}